Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TAPENTADOL

TAPENTADOL

Standard Dose
200MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary

Approval overview TAPENTADOL is listed in Drugs@FDA under application 206418 (ANDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient TAPENTADOL Form and strength TABLET, EXTENDED RELEASE;ORAL - 200MG Sponsor WEST-WARD PHARMS INT Submission history Latest submission status date: 2026-02-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview TAPENTADOL is listed in Drugs@FDA under application 206418 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient TAPENTADOL Form and strength TABLET, EXTENDED RELEASE;ORAL - 200MG Sponsor WEST-WARD PHARMS INT Submission history Latest submission status date: 2026-02-13 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.